Lung Fibrosis Drug Lowers Biological Age Estimates
Six different aging clocks detected younger blood protein profiles in patients taking the experimental lung-fibrosis drug rentosertib.
Useful takeaways from this story.
Six different aging clocks detected younger blood protein profiles in patients taking the experimental lung-fibrosis drug rentosertib.
Building the complete brief
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The useful part
Six different aging clocks detected younger blood protein profiles in patients taking the experimental lung-fibrosis drug rentosertib.
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.